Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Promius Pharma, a branded specialty company, has launched Scytera for the treatment of chronic psoriasis. Scytera foam delivers coal tar in a cosmetically-elegant, patient-pleasing foam vehicle.
Subscribe to our email newsletter
Scytera foam is said to be the first coal tar product in an aerosol foam vehicle to be launched into the psoriasis market.
Studies have demonstrated that coal tar treatment of psoriasis results in a reduction in the overproduction of skin cells, a reduction of itch and a promotion of healthy skin, the company said.
According to the company, Scytera foam’s technology allows the product to be spread easily and smoothly over large body areas. Along with the foam technology, Scytera foam uses a patented odor neutralizing system to minimize the coal tar odor.
Jeffrey Wasserstein, president of Promius, said: “We believe Scytera foam will be of significant benefit to dermatologists and their patients, enhancing the value and re-establishing the importance of coal tar for psoriasis treatment.”